Patrick J. Mcenany - Dec 8, 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chairman and CEO, Director
Signature
/s/ Patrick J. McEnany
Stock symbol
CPRX
Transactions as of
Dec 8, 2023
Transactions value $
$0
Form type
4
Date filed
12/12/2023, 05:00 PM
Previous filing
May 17, 2023
Next filing
Dec 29, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Award $0 +73.8K +2.52% $0.00 3M Dec 8, 2023 Common Stock 73.8K $14.15 Direct F1
transaction CPRX Restricted Stock Units Award $0 +10.6K +0.35% $0.00 3.01M Dec 8, 2023 Common Stock 10.6K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Derivative securities vest in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025 and 1/3rd on December 8, 2026.
F2 Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F3 Shares of common stock will be delivered to the Reporting Person upon vesting.